| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC0273 |
| Trial ID | NCT02588612 |
| Disease | Neoplasm |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | Letetresgene autoleucel|GSK3377794|Lete-cel |
| HLA | HLA-A*02 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Pilot Open-Label Clinical Trial Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs Specific for NY-ESO-1 in Subjects With Stage IIIb or Stage IV Non-Small Cell Lung Cancer (NSCLC) |
| Year | 2015 |
| Country | United States |
| Company sponsor | GlaxoSmithKline |
| Other ID(s) | 208749|ADP-0011-004|2016-002517-21 |
| Cohort 1 | |||||||||||||||
|
|||||||||||||||